Anthony Paronneau participated in a round-table discussion alongside prominent speakers at the LES (Licensing Executives Society) France Conference. The panel discussed in depth agreements between biotech companies and universities, as well as agreements between pharmaceutical and biotech businesses. In particular, the speakers focused on the recommended Do’s and Don’ts of these arrangements.
